Marshall Wace
EPZM

Marshall Wace’s Epizyme, Inc EPZM Stock Holding History

Marshall Wace’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-207,760
Closed -$1.81M – 3394
2021
Q1 		$1.81M Buy
+207,760
New +$2.15M 0.01% 1378
2020
Q3 		– Sell
-74,397
Closed -$1.2M – 2032
2020
Q2 		$1.2M Buy
74,397
+36,158
+95% +$631K 0.01% 949
2020
Q1 		$593K Buy
+38,239
New +$821K 0.01% 940
2019
Q2 		– Sell
-191,674
Closed -$2.38M – 1996
2019
Q1 		$2.38M Sell
191,674
-390,429
-67% -$4.36M 0.02% 689
2018
Q4 		$3.58M Buy
582,103
+264,052
+83% +$2.02M 0.04% 557
2018
Q3 		$3.37M Buy
+318,051
New +$3.63M 0.03% 552
2018
Q2 		– Sell
-64,651
Closed -$1.15M – 891
2018
Q1 		$1.15M Buy
+64,651
New +$1.09M 0.05% 253
2015
Q4 		– Sell
-133,714
Closed -$1.72M – 1173
2015
Q3 		$1.72M Buy
133,714
+83,735
+168% +$1.69M 0.02% 490
2015
Q2 		$1.2M Buy
49,979
+14,314
+40% +$275K 0.02% 567
2015
Q1 		$669K Buy
+35,665
New +$736K 0.01% 641
2014
Q4 		– Sell
-26,059
Closed -$706K – 1028
2014
Q3 		$706K Buy
26,059
+17,577
+207% +$546K 0.01% 602
2014
Q2 		$264K Buy
+8,482
New +$200K ﹤0.01% 784

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Marshall Wace's EPZM Position: Q2 2021 in Review

Marshall Wace sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 207,760 shares — an estimated $1.81M sold.

Marshall Wace first reported a position in EPZM in Q2 2014 and held it in 12 quarters. The position peaked at $3.58M in Q4 2018. 127 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Marshall Wace reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace sold 207,760 Epizyme, Inc shares in Q2 2021, an estimated $1.81M.
  • Marshall Wace first reported a position in Epizyme, Inc in Q2 2014 and held it in 12 quarters.
  • Marshall Wace's Epizyme, Inc position peaked at $3.58M in Q4 2018.
  • 127 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.